RIGEL PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Rigel Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.64M, a 36.1% increase year-over-year.
  • Rigel Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.2M, a 11.7% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $8.81M, a 28.9% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $12.4M, a 30.6% increase from 2021.
  • Rigel Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $9.49M, a 30% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12.2M $2.64M +$701K +36.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11.5M $2.53M +$356K +16.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $11.2M $5.13M +$2.38M +86.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $8.81M $1.93M -$2.15M -52.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $11M $1.94M -$764K -28.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $11.7M $2.17M -$219K -9.16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $11.9M $2.76M -$449K -14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $12.4M $4.08M +$1.74M +74.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $10.6M $2.71M +$505K +22.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $10.1M $2.39M +$85K +3.69% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $10.1M $3.21M +$568K +21.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $9.49M $2.34M +$709K +43.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $8.78M $2.2M +$318K +16.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.46M $2.31M +$549K +31.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $7.91M $2.64M +$615K +30.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $7.3M $1.63M +$219K +15.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $7.08M $1.88M -$214K -10.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $7.29M $1.76M -$896K -33.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $8.19M $2.02M -$929K -31.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.12M $1.41M -$646K -31.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $9.76M $2.1M -$897K -30% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $10.7M $2.65M +$1.54M +139% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $9.12M $2.95M +$1.41M +91.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $7.7M $2.06M -$1M -32.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 $8.71M $3M +$2.12M +243% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $6.58M $1.11M +$12K +1.09% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $6.57M $1.54M +$585K +61.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $5.99M $3.06M +$393K +14.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $5.59M $873K -$841K -49.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $6.44M $1.1M -$914K -45.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $7.35M $955K -$483K -33.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $7.83M $2.67M +$1.04M +64.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $6.79M $1.71M -$101K -5.57% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $6.89M $2.01M +$105K +5.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $6.79M $1.44M -$616K -30% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $7.4M $1.63M +$125K +8.33% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $7.28M $1.82M -$265K -12.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $7.54M $1.91M -$223K -10.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $7.77M $2.05M -$310K -13.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $8.08M $1.5M -$63K -4.03% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 $8.14M $2.08M +$17K +0.82% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $8.12M $2.13M +$385K +22% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $7.74M $2.36M +$571K +31.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $7.17M $1.56M -$1.7M -52.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 $8.87M $2.06M -$1.18M -36.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $10M $1.75M -$1.26M -42% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $11.3M $1.79M -$1.31M -42.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $12.6M $3.26M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $3.25M +$155K +5.02% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $3.01M -$189K -5.91% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $3.1M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q3 2011 $3.09M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $3.2M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.